Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/05/2008EP1319000B1 Use of 1-azabicyclo 2.2.2 octan-3-one derivatives for treating cancer tumors
11/05/2008EP1200424B1 C7 heterosubstituted acetate taxanes as antitumor agents
11/05/2008EP1196193B1 Interleukin-1 mutein useful as vaccine adjuvant
11/05/2008EP1150712B1 Human papilloma virus vaccine formulations
11/05/2008EP1124550B9 Uses and compositions for selective cancer chemotherapy
11/05/2008EP1109937B1 METHOD OF DIAGNOSING, MONITORING, STAGING, and IMAGING VARIOUS CANCERS
11/05/2008CN101300272A Compositions and methods for treating proliferative disorders
11/05/2008CN101300258A 5-OXO-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
11/05/2008CN101300251A Benzimidazole thiophene compounds as PLK inhibitor
11/05/2008CN101300234A Compounds and compositions for protein kinase inhbitors
11/05/2008CN101300233A Azafused cyclin dependent kinase inhibitors
11/05/2008CN101300231A Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
11/05/2008CN101300014A Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
11/05/2008CN101300011A Formulations comprising jorumycin-, reni eramycin-, safracin- or saframycin-related compounds for treating proliferative diseases
11/05/2008CN101298482A Dextran
11/05/2008CN101298472A Growth inhibition hormone peptide derivatives and preparation thereof
11/05/2008CN101297970A Antimetabolites and potentiating agent thereof carried by anticancer sustained-release injection
11/05/2008CN101297966A Tumor vaccine for intestinal cancer containing rich chaperone-antigenic peptide complexes and preparation thereof
11/05/2008CN101297940A Medicament for treating tumor and cancer and preparation method
11/05/2008CN101297818A Animal sperm medicinal materials and uses thereof in medicaments for curing tumor, depression and multiple diseases
11/05/2008CN101297810A Uses of Arctium lappa oligofructose in medicament or health care food
11/05/2008CN101297796A Grifola frondosa beta-dextran freeze-dried powder for injection
11/05/2008CN101297711A Drink containing anticancer food
11/05/2008CN101297692A Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products
11/05/2008CN101297670A Sugar containing anticancer food
11/05/2008CN101297667A Dandelion health-care tea and preparing process thereof
11/05/2008CN100430482C Novel expression vectors and uses thereof
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430476C Tumor-lysing virus growing selectively in tumor cells
11/05/2008CN100430420C Human CDR-grafted antibodies and antibody fragments thereof
11/05/2008CN100430419C Anti-CD40 monoclonal antibody
11/05/2008CN100430416C New alpha - conantokins, coded polynucleotide and application
11/05/2008CN100430412C Nucleic acid molecule RTN4BSR6 and application for preparation of anti-cancer drugs
11/05/2008CN100430409C Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone
11/05/2008CN100430361C Quinone compounds and its preparation method and antineoplastic use
11/05/2008CN100430359C Active compound bulbophyllum phenanthrene dimer A and its use
11/05/2008CN100430065C Application of paris polyphyla var. yunnanensis stem and leaf monomer saponin in pharmaceutical industry
11/05/2008CN100430064C Use of scutellarin in inhibiting vascularization
11/05/2008CN100430060C Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders
11/05/2008CN100430058C Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
11/05/2008CN100430054C Use of green chiretta diterpene lactone in inhibiting vascularization
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/04/2008US7446209 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446179 CD19-specific chimeric T cell receptor
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7445784 Apoptosis of rectum and prostate cancer
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445764 Carrier-drug conjugate
10/2008
10/30/2008WO2008131354A2 Phytoestrogens as regulators of hedgehog signaling and methods of their use in cancer treatment
10/30/2008WO2008131267A2 Low calcemic, highly antiproliferative, analogs of calcitriol
10/30/2008WO2008131253A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008WO2008131242A1 Single chain fc, methods of making and methods of treatment
10/30/2008WO2008131227A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008WO2008131134A1 Hydrazide compounds and uses thereof
10/30/2008WO2008131114A2 Pharmaceutical formulations containing lipoic acid derivatives
10/30/2008WO2008131103A2 Drug discovery methods for aurora kinase inhibitors
10/30/2008WO2008131050A1 Pyrrolotriazine kinase inhibitors
10/30/2008WO2008131000A2 7-substituted indole mcl-1 inhibitors
10/30/2008WO2008130970A1 7-nonsubstituted indole mcl-1 inhibitors
10/30/2008WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
10/30/2008WO2008130944A1 Solid phase syntheses of amino pyrimidine compounds
10/30/2008WO2008130879A2 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008WO2008130570A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/30/2008WO2008130569A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/30/2008WO2008130552A1 Triazole derivatives which are smo antagonists
10/30/2008WO2008130370A1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
10/30/2008WO2008130216A1 Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith
10/30/2008WO2008130036A1 Method for production of antimutagenic substance using lactic acid bacterium
10/30/2008WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008129874A1 Method of targeting tumor cell and use of the same
10/30/2008WO2008129530A1 Gemcitabine production process
10/30/2008WO2008129380A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
10/30/2008WO2008129288A2 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008129258A1 New use for cannabinoid-containing plant extracts
10/30/2008WO2008129255A1 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
10/30/2008WO2008129080A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
10/30/2008WO2008129075A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds
10/30/2008WO2008128792A1 Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
10/30/2008WO2008128786A1 Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
10/30/2008WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
10/30/2008WO2008128440A1 A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
10/30/2008WO2008128428A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008WO2008128366A1 Active ingredient combination for the prophylaxis of occlusive vascular diseases and cancer
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008128295A1 Essential oil of kunzea ambigua and methods of use
10/30/2008WO2008110379A3 Monoclonal antibodies for treatment of cancer
10/30/2008WO2008109380A3 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
10/30/2008WO2008106692B1 Pim kinase inhibitors and methods of their use
10/30/2008WO2008104812A3 C21-de0xy ansamycin derivatives as antitumor agents
10/30/2008WO2008100985A3 Combination of lbh589 with other therapeutic agents for treating cancer
10/30/2008WO2008089883A3 Tri-demethylation-capable protein complex, method of its preparation and its use
10/30/2008WO2008071093A8 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10
1 ... 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 ... 2211